Profound neuronal plasticity in response to inactivation of the dopamine transporter

Proceedings of the National Academy of Sciences of the United States of America

Volumn 95, Issue 7, 1998, Pages 4029-4034

  Jones, Sara R ^a   Gainetdinov, Raul R ^a   Jaber, Mohamed ^a,b   Giros, Bruno ^a,c   Wightman, R Mark ^d   Caron, Marc G ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b CNRS   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; DOPAMINE TRANSPORTER; PSYCHOSTIMULANT AGENT; TYROSINE 3 MONOOXYGENASE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINERGIC SYSTEM; DRUG ABUSE; MOUSE; NERVE CELL PLASTICITY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM;

ANIMALS; BRAIN; CARRIER PROTEINS; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; GENE DELETION; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, MUTANT STRAINS; NERVE TISSUE PROTEINS; NEURONAL PLASTICITY;

EID: 0032584230     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.95.7.4029     Document Type: Article

References (43)

1. Amara, S. G. & Kuhar, M. J. (1993) Annu. Rev. Neurosci. 16, 73-93.
2. Feldman, R. S., Meyer, J. S. & Quenzer, L. F. (1997) Principles of Neuropsycho-Pharmacology (Sinauer, Sunderland, MA), Chapt. 8 and 9.
3. Horn, A. S. (1990) Prog. Neurobiol 34, 387-400.
4. Nirenberg, M. J., Chan, J., Pohorille, A., Vaughan, R. A., Uhl, G. R., Kuhar, M. J. & Picel, V. M. (1997) J. Neurosci. 17, 6899-6907.
5. Garris, P. A., Ciolkowski, E. L., Pastore, P. & Wightman, R. M. (1994) J. Neurosci. 14, 6084-6093.
6. Agnati, L. F., Bjelke, B. & Fuxe, K. (1995) Med. Res. Rev. 15, 33-45.
7. Koob, G. F. & Bloom, F. E. (1988) Science 242, 715-723.
8. Ritz, M. C., Lamb, R. J., Goldberg, S. R. & Kuhar, M. J. (1987) Science 237, 1219-1223.
9. Volkow, N. D., Wang, G.-J., Fischman, M. W., Foltin, R. W., Fowler, J. S., Abumrad, N. N., Vitkun, S., Logan, J., Galley, S. J., Pappas, N., Hitzemann, R. & Shea, C. E. (1997) Nature (London) 386, 827-830.
10. Kopin, I. J. (1985) Pharmacol. Rev. 37, 333-364.
11. Giros, B., Jaber, M., Jones, S. R., Wightman, R. M. & Caron, M. G. (1996) Nature (London) 379, 606-612.
12. Jones, S. R., Garris, P. A., Kilts, C. D. & Wightman, R. M. (1995) J. Neurochem. 64, 2581-2589.
13. Kawagoe, K. T., Zimmerman, J. B. & Wightman, R. M (1993) J. Neurosci. Methods 48, 225-240.
14. Ungerstedt, U. (1984) in Measurement of Neurotransmitter Release in Vivo, ed. Marsden, C. A. (Wiley, Chicester, U.K.), pp. 81-105.
15. Franklin, K. B. J. & Paxinos, G. (1997) The Mouse Brain in Stereotaxic Coordinates (Academic, San Diego).
16. Bungay, P. M. Morrison, P. F. & Dedrick, R. L. (1990) Life Sci. 46, 105-119.
17. Justice, J. B., Jr. (1993) J. Neurosci. Methods 48, 263-276.
18. Carlsson, A., Davis, J. N., Kehr, W., Lindqvist, M. & Atack, C. V. (1972) Naunyn Schmeideberg's Arch Pharmacol. 275, 153-168.
19. Blank, C. L. &. Pike, R (1976) Life Sci. 18, 859-865.
20. Kaakkola, S., Mannisto, P. T. & Nissinen, E. (1987) J. Neural Trans. 69, 221-228.
21. Freeman, K. B., Bulawa, M. C., Zeng, Q. & Blank, C. L. (1993) Anal. Biochem. 208, 182-196.
22. Scherman, D. & Henry, J.-P. (1980) Biochem. Pharmacol. 29, 1883-1890.
23. Near, J. A. (1986) Mol. Pharmacol. 30, 252-257.
24. Kaakkola, S. J. & Wurtman, R. J. (1992) Brain Res. 587, 241-249.
25. Nicholson, C. (1995) Biophys. J. 68, 1699-1715.
26. Near, J. A., Bigelow, J. C. & Wightman, R. M. (1988) J. Pharmacol. Exp. Ther. 245, 921-927.
27. Pelton, E. W., Kimelberg, H. K., Shipherd, S. V. & Bourke, R. S. (1981) Life Sci. 28, 1655-1663.
28. Ribeiro, P., Wang, Y., Citron, B. A. & Kaufman, S. (1992) Proc. Natl. Acad. Sci. USA 89, 9593-9597.
29. Spector, S., Gordon, R., Sjoerdsma, A. & Udenfriend, S. (1967) Mol. Pharmacol. 3, 549-555.
30. Wolf, M. E. & Roth, R. H. (1990) in Presynaptic Receptors and the Question of Autoregulation of Neurotransmitter Release, eds. Kalsner, S. & Westfall, T. C. (NY Academy of Sciences, New York), Vol. 604, pp. 323-343.
31. Roth, R. H., Murrin, L. C. & Walters, J. R. (1976) Eur. J. Pharmacol. 36, 163-171.
32. Zetterstrom, T., Sharp, T., Collin, A. K. & Ungerstedt, U. (1988) Eur. J. Pharmacol. 148, 327-334.
33. Goldstein, M. (1995) in Psychopharmacology: The Fourth Generation of Progress, eds. Bloom, F. E. & Kupfer, D. J. (Raven, New York), pp. 189-195.
34. Groves, P. M., Linder, J. C. & Young, S. J. (1994) Neuroscience 58, 593-604.
35. Garris, P. A. & Wightman, R. M. (1994) J. Neurosci. 14, 442-450.
36. Fuxe, K. & Agnati, L. F. (1991) in Advances in Neuroscience, eds. Fuxe, K. &. Agnati, L. F. (Raven, New York), Vol. 1, pp. 1-10.
37. Bannon, M. J., Michaud, R. L. & Roth, R. H. (1981) Mol. Pharmacol. 19, 270-275.
38. Volkow, N. D., Wang, G.-J., Fowler, J. S., Logan, J., Galley, S. J., Hitzemann, R., Chen, A. D., Dewey, S. L. & Pappas, N. (1997) Nature (London) 386, 830-833.
39. Wilson, J. M., Levey, A. I., Bergeron, C., Kalaisinsky, K., Ang, L. Peretti, F., Adams, V. I., Smialek, J., Anderson, W. R., Shannak, K., Deck, J., Niznik, H. B. & Kish, S. J. (1996) Necrology 47, 718-726.
40. Wilson, J. M., Kalaisinsky, K., Levey, A. I., Bergeron, C., Reiber, G., Anthony, R. M., Schmunk, G. A., Shannak, K., Haycock, J. W. & Kish, S. J. (1996) Nat. Med. 2, 699-703.
41. Dackis, C. A. & Gold, M. S. (1985) Neurosci. Neurobehav. Rev. 9, 469-477.
42. Gawin, F. H. & Kleber, H. D. (1986) Arch. Gen Psychiatry 43, 107-113.
43. Robinson, T. E. & Berridge, K. C. (1993) Brain Res. Rev. 18, 247-291.